tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

dorsaVi Limited Announces Quotation of New Securities on ASX

Story Highlights
dorsaVi Limited Announces Quotation of New Securities on ASX

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

dorsaVi Limited ( (AU:DVL) ) has shared an update.

dorsaVi Limited has announced the application for quotation of 12,500,000 ordinary fully paid securities on the Australian Securities Exchange (ASX), with an issue date of August 20, 2025. This move is part of previously announced transactions and represents a strategic effort to enhance the company’s capital structure, potentially impacting its market position and providing new opportunities for stakeholders.

More about dorsaVi Limited

dorsaVi Limited operates in the health technology industry, focusing on developing and providing innovative motion analysis devices and software. These products are primarily used for clinical and occupational health applications, enabling detailed movement assessments and data-driven insights for healthcare professionals and organizations.

Average Trading Volume: 5,311,853

Technical Sentiment Signal: Buy

Current Market Cap: A$39.18M

For detailed information about DVL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1